GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Pro Medicus Ltd (ASX:PME) » Definitions » EV-to-FCF

Pro Medicus (ASX:PME) EV-to-FCF : 173.83 (As of May. 01, 2024)


View and export this data going back to 2000. Start your Free Trial

What is Pro Medicus EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Pro Medicus's Enterprise Value is A$11,277.4 Mil. Pro Medicus's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was A$64.9 Mil. Therefore, Pro Medicus's EV-to-FCF for today is 173.83.

The historical rank and industry rank for Pro Medicus's EV-to-FCF or its related term are showing as below:

ASX:PME' s EV-to-FCF Range Over the Past 10 Years
Min: -346.32   Med: 115.73   Max: 359.24
Current: 174.04

During the past 13 years, the highest EV-to-FCF of Pro Medicus was 359.24. The lowest was -346.32. And the median was 115.73.

ASX:PME's EV-to-FCF is ranked worse than
95.62% of 365 companies
in the Healthcare Providers & Services industry
Industry Median: 19.64 vs ASX:PME: 174.04

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-01), Pro Medicus's stock price is A$109.25. Pro Medicus's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was A$0.666. Therefore, Pro Medicus's PE Ratio for today is 164.04.


Pro Medicus EV-to-FCF Historical Data

The historical data trend for Pro Medicus's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pro Medicus EV-to-FCF Chart

Pro Medicus Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 151.27 115.05 194.57 82.16 120.08

Pro Medicus Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 82.16 - 120.08 -

Competitive Comparison of Pro Medicus's EV-to-FCF

For the Health Information Services subindustry, Pro Medicus's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pro Medicus's EV-to-FCF Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Pro Medicus's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Pro Medicus's EV-to-FCF falls into.



Pro Medicus EV-to-FCF Calculation

Pro Medicus's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=11277.439/64.876
=173.83

Pro Medicus's current Enterprise Value is A$11,277.4 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Pro Medicus's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was A$64.9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pro Medicus  (ASX:PME) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Pro Medicus's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=109.25/0.666
=164.04

Pro Medicus's share price for today is A$109.25.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Pro Medicus's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was A$0.666.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Pro Medicus EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Pro Medicus's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Pro Medicus (ASX:PME) Business Description

Traded in Other Exchanges
Address
450 Swan Street, Richmond, Melbourne, VIC, AUS, 3121
Pro Medicus is a healthcare IT company specializing in radiology imaging software. Its main product, Visage 7, is a clinical desktop application that radiologists use to view, enhance, and manipulate images from any device and make a diagnosis. Its main customers are U.S. private academic hospitals. In fiscal 2022, Pro Medicus earned 79% of revenue in North America, 16% from Australia, and the remaining 6% in Europe.